If you are free on Thursday, October 10th from 10 a.m.-11 a.m. MT, you may wish to attend this free webinar. Based on the description of the session, it is going to be time well spent. Register here.
Join patient partners and thought leaders in an engaging panel discussion on the value of patient and family partnerships. Learn first-hand about what works well for partnering with patients and families, what doesn’t and tips for collaborating on your system transformation and organizational quality improvement initiatives. This webinar features panelists who have a range of collaboration experience, including at organizational, health system and policy maker levels.
If you live in Saskatoon or area, this is something you will want to check out. Atlthough this true event is incredibly sad, Greg’s Story has the potential of bringing about some positive changes to healthcare. In doing so, the hope is to see fewer people falling through the cracks.
Are you interested in home (personal) health monitoring technologies and ways they can be used to improve patient care in Alberta? If so, here is an event you may find of interest.
Click here to read and download the forum information.
If you are take any medication, whether it be doctor initiated prescriptions, over-the-counter drugs or herbal remedies, you are apt to be doing do so in hopes of getting a particular outcome (e.g., less pain, greater mobility, etc.) However, can the medication you are taking actually make you sicker? Unfortunately, the answer is “Yes.” Click here to find out more.
Did you miss the sold out first screening to "Movie to Movement: Creating the future of healthcare together". Here's your chance to join @gregswings this Tuesday night and participate! See you there? https://t.co/5FqKj8NbH9 via @Eventbrite
Health Canada is modernizing its approach to disclosing clinical information on drugs and medical devices to support advances in medical science and help improve patient care. Today, Health Canada published draft regulations in Canada Gazette l that propose to make clinical information in drug and medical device submissions publicly available after the Department has completed its regulatory review process.